In May 2022, The US FDA authorized the use of RADICAVA ORS (edaravone) in an oral formulation for the treatment of ALS.

High HPV vaccination rates in Swedish schools significantly lower cervical cancer lesion rates, highlighting the importance ...

Wearable health devices, such as smartwatches, have become commonplace, enabling the continuous monitoring of physiological ...

ICE recently purchased two programs called Tangles and Webloc, which are used to track the cell phone activity of entire ...